Peripherally Inserted Central Catheters (PICC), UPN H965750191, Catalog # 75-019 The Maximal ...
FDA Device Recall #Z-0715-2017 — Class II — June 8, 2016
Recall Summary
| Recall Number | Z-0715-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 8, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Angiodynamics Inc. (Navilyst Medical Inc.) |
| Location | Glens Falls, NY |
| Product Type | Devices |
| Quantity | 50 cartons (boxes of 5) |
Product Description
Peripherally Inserted Central Catheters (PICC), UPN H965750191, Catalog # 75-019 The Maximal Barrier Nursing Kits are Tandem Pack Convenience Kits packaged with a NMI PICC and accessories. The BioFlo PICC with ENDEXO Technology and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.
Reason for Recall
There is a potential for stylet stiffening that is not accurately represented on the labeling. The label states that product includes a stylet with an outside diameter (OD) measuring 0.014, however, the product may contain a stylet with an outside diameter (OD) measuring 0.016.
Distribution Pattern
Nationwide Distribution to CA, FL, GA, HI, LA, MI, MN, MO, NV, OH & TX
Lot / Code Information
Lot #: 4945781
Other Recalls from Angiodynamics Inc. (Navilyst Medical ...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1467-2021 | Class II | AngioDynamics Safe Sheath Ultralite - Vascular ... | Feb 22, 2021 |
| Z-1466-2021 | Class II | Smart Port CT-Implantable Port Catalogue #: CT9... | Feb 22, 2021 |
| Z-0411-2020 | Class II | Starburst Talon Semi-Flex Electrosurgical Devic... | Oct 2, 2019 |
| Z-0504-2020 | Class II | BIOFLO 8F SINGLE PLASTIC FILLED; VALVED, UPN H9... | Sep 18, 2019 |
| Z-0501-2020 | Class II | BIOFLO 8F SINGLE PLASTIC FILLED; NON-VALVED, UP... | Sep 18, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.